Tandem Diabetes Care Dirección
Dirección controles de criterios 4/4
El CEO de Tandem Diabetes Care's es John Sheridan , nombrado en Apr 2013, tiene una permanencia de 4.83 años. compensación anual total es $4.65M, compuesta por 15.3% salario y 84.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.046% de las acciones de la empresa, por valor de $1.06M. La antigüedad media del equipo directivo y de la junta directiva es de 2.6 años y 4.3 años, respectivamente.
Información clave
John Sheridan
Chief Executive Officer (CEO)
US$4.7m
Compensación total
| Porcentaje del salario del CEO | 15.3% |
| Permanencia del CEO | 11yrs |
| Participación del CEO | 0.05% |
| Permanencia media de la dirección | 2.6yrs |
| Promedio de permanencia en la Junta Directiva | 4.3yrs |
Actualizaciones recientes de la dirección
Recent updates
At US$30.10, Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Worth Looking At Closely?
Mar 26
Even With A 27% Surge, Cautious Investors Are Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
Mar 08Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Feb 22Estimating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jan 14Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Rockets 63% But Many Are Still Ignoring The Company
Dec 27Is It Too Late To Consider Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Nov 12Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 53% Above Its Share Price
Oct 06Does Tandem Diabetes Care (NASDAQ:TNDM) Have A Healthy Balance Sheet?
Sep 17Should You Think About Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Now?
Aug 08Calculating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jul 03Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt Sensibly?
Jun 13Cautious Investors Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
May 06Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Jan 04Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Potentially Undervalued?
Oct 15Tandem Diabetes Care: Overpriced, Underdelivering
Sep 22An Intrinsic Calculation For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Suggests It's 50% Undervalued
Sep 10Tandem Diabetes stock falls 10% on disappointing Q2 result
Aug 03Tandem Diabetes Care acquires Capillary Biomedical; terms undisclosed
Jul 21Tandem Diabetes Care: Strong Financials And Revenue, Overpenalized For Missed Earnings
Jul 08Tandem Diabetes Care (NASDAQ:TNDM) Is Looking To Continue Growing Its Returns On Capital
Jun 20Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 43% Above Its Share Price
May 30Here's Why Tandem Diabetes Care (NASDAQ:TNDM) Can Manage Its Debt Responsibly
Apr 17Tandem Diabetes Care: Medical Instruments And Supplies Spell Market Success
Apr 01Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$5m | US$711k | -US$223m |
| Sep 30 2023 | n/a | n/a | -US$208m |
| Jun 30 2023 | n/a | n/a | -US$224m |
| Mar 31 2023 | n/a | n/a | -US$204m |
| Dec 31 2022 | US$6m | US$711k | -US$95m |
| Sep 30 2022 | n/a | n/a | -US$68m |
| Jun 30 2022 | n/a | n/a | -US$13m |
| Mar 31 2022 | n/a | n/a | US$6m |
| Dec 31 2021 | US$6m | US$690k | US$16m |
| Sep 30 2021 | n/a | n/a | US$22m |
| Jun 30 2021 | n/a | n/a | US$7m |
| Mar 31 2021 | n/a | n/a | -US$25m |
| Dec 31 2020 | US$4m | US$600k | -US$34m |
| Sep 30 2020 | n/a | n/a | -US$49m |
| Jun 30 2020 | n/a | n/a | -US$42m |
| Mar 31 2020 | n/a | n/a | -US$17m |
| Dec 31 2019 | US$11m | US$500k | -US$25m |
| Sep 30 2019 | n/a | n/a | -US$24m |
| Jun 30 2019 | n/a | n/a | -US$55m |
| Mar 31 2019 | n/a | n/a | -US$113m |
| Dec 31 2018 | US$2m | US$386k | -US$123m |
| Sep 30 2018 | n/a | n/a | -US$138m |
| Jun 30 2018 | n/a | n/a | -US$119m |
| Mar 31 2018 | n/a | n/a | -US$82m |
| Dec 31 2017 | US$596k | US$375k | -US$73m |
Compensación vs. Mercado: La compensación total ($USD4.65M) de John está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD5.61M).
Compensación vs. Ingresos: La compensación de John ha sido consistente con los resultados de la empresa en el último año.
CEO
John Sheridan (68 yo)
11yrs
Permanencia
US$4,651,603
Compensación
Mr. John F. Sheridan has been President and Chief Executive Officer at Tandem Diabetes Care, Inc., since March 01, 2019 and served as its Chief Operating Officer and Executive Vice President since April 20...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 11yrs | US$4.65m | 0.046% $ 1.1m | |
| Executive VP | 6.3yrs | US$1.25m | 0.038% $ 909.9k | |
| Executive VP & Chief Administrative Officer | 10.6yrs | US$1.25m | 0.024% $ 566.9k | |
| Transitional Advisor | less than a year | US$1.25m | 0.011% $ 256.1k | |
| Executive Officer | 8.2yrs | US$1.27m | 0.021% $ 487.5k | |
| Executive Vice President and Chief Strategy & Product Officer | 2.8yrs | US$1.25m | 0.010% $ 235.7k | |
| Executive VP & Chief Commercial Officer | less than a year | US$2.72m | sin datos | |
| Chief Technical Officer | 2.4yrs | sin datos | 0.0095% $ 223.9k | |
| Executive VP | 2.3yrs | sin datos | 0.0085% $ 202.3k | |
| Chief Human Resources Officer | 6.7yrs | sin datos | sin datos | |
| Chief Medical Officer | less than a year | sin datos | sin datos | |
| Senior Vice President of Customer Care | 2.4yrs | sin datos | sin datos |
2.6yrs
Permanencia media
53yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de TNDM se considera experimentado (2.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 4.8yrs | US$4.65m | 0.046% $ 1.1m | |
| Independent Chairwoman of the Board | 5.3yrs | US$222.78k | 0.0077% $ 182.2k | |
| Director | 16.6yrs | US$198.78k | 0.34% $ 8.0m | |
| Independent Director | 10.8yrs | US$200.95k | 0.030% $ 716.8k | |
| Independent Director | 16.8yrs | US$214.67k | 0.074% $ 1.8m | |
| Independent Director | 3.7yrs | US$190.28k | 0.019% $ 449.6k | |
| Independent Director | 3.3yrs | US$189.25k | 0.010% $ 245.9k | |
| Independent Director | 3.8yrs | US$189.25k | 0.014% $ 331.4k | |
| Independent Director | 1.8yrs | US$176.55k | 0.0027% $ 64.2k | |
| Independent Director | 1.8yrs | US$177.55k | 0.0027% $ 64.2k |
4.3yrs
Permanencia media
60.5yo
Promedio de edad
Junta con experiencia: La junta directiva de TNDM se considera experimentada (4.3 años de antigüedad promedio).